Advanced Recurrent Ovarian Cancer

Links shared publicly online about this topic

Drug-Treatment Opportunities In Advanced Ovarian Cancer Will Be Limited By A Reduced Risk Of Disease Recurrence

medicalnewstoday.com — “Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that projected improvements in recurrence-free survival and an only modesView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on December 9, 2010 at 6:05 pm By:

mnt_ovariancanc MNT Ovarian Cancer Health News

Drug-Treatment Opportunities In Advanced Ovarian Cancer Will Be Limited By A Reduced Risk Of Disease Recurrence http://mnt.to/3NP9

1 year ago...

First Recurrent Gene Fusion Identified In Ovarian Cancer

medicalnewstoday.com — “Researchers studying ovarian cancer have discovered that, in a substantial fraction of ovarian tumors, a gene closely related to the estrogen receptor is broken and fused to an adjacent gene by aView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on September 22, 2011 at 7:05 am By:

mnt_ovariancanc MNT Ovarian Cancer Health News

First Recurrent Gene Fusion Identified In Ovarian Cancer http://mnt.to/3ZMY #ovariancancer

8 months ago...

Treatment for Advanced Ovarian Cancer Effective

disabled-world.com — “New treatment regimen shown effective against advanced ovarian cancerView full resource at disabled-world.com

  • View Related
  • Share

Most Recently Shared on June 6, 2010 at 11:31 pm By:

Phase 2 study of aflibercept for the treatment of advanced ovarian cancer with ascites - MPR

empr.com — “Sanofi-aventis and Regeneron Pharmaceuticals announced data from a Phase 2 trial for their fusion protein product, aflibercept (VEGF Trap), in the treatment of advanced ovarian cancer patients with recurrent symptomatic malignant ascites (SMA).View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on June 11, 2009 at 6:34 pm By:

eMPR MPR Medical Publisher

MPR News: Phase 2 study of aflibercept for the treatment of advanced ovarian cancer with ascites: Sanof.. http://tinyurl.com/mobhuq

3 years ago...

Ovarian Cancer: eMedicine Oncology

emedicine.medscape.com — “Overview: Ovarian cancer is the most common cause of cancer death from gynecologic tumors in the United States. Early disease causes minimal, nonspecific, or no symptoms. Therefore, most cases are diagnosed in an advanced stage. Overall, prognosis ...View full resource at emedicine.medscape.com

  • View Related
  • Share

Most Recently Shared on April 12, 2010 at 6:04 pm By:

MedscapeOnc Medscape Oncology Oncology and Health Site

Ovarian Cancer: Study finds cytoreductive surgery safe and effective in platinum-sensitive recurrent ovarian cancer. http://bit.ly/9ZmUBA

2 years ago...

Ovarian cancer vaccine: Can it prevent recurrence? - MayoClinic.com

mayoclinic.com — “Research continues to evaluate the role of an ovarian cancer vaccine to prevent recurrence.View full resource at mayoclinic.com

  • View Related
  • Share

Most Recently Shared on March 24, 2012 at 2:20 am By:

J_Bohlen Julie Bohlen Health Executive and Active Health Library

Ovarian cancer vaccine: Can it prevent recurrence?: Research continues to evaluate the role of an ovarian cancer... http://t.co/fbwU0zDZ

2 months ago...

EGEN, Inc. Announces That Phase II Clinical Trial For Advanced Ovarian Cancer Is Open For Enrollment

medicalnewstoday.com — “EGEN, Inc. announced that the first Phase II clinical trial utilizing EGEN-001 for the treatment of recurrent ovarian cancer is now open for enrollment. The trial is sponsored by the GynecologicView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on December 15, 2010 at 6:05 pm By:

mnt_ovariancanc MNT Ovarian Cancer Health News

EGEN, Inc. Announces That Phase II Clinical Trial For Advanced Ovarian Cancer Is Open For Enrollment http://mnt.to/3P6r #ovariancancer

1 year ago...

Updated AMG 386 Data Demonstrate Promising Antitumor Activity in Patients With Recurrent Ovarian Cancer - Drugs.com MedNews

drugs.com — “THOUSAND OAKS, Calif., Amgen (Nasdaq AMGN) today announced AMG 386, combined with paclitaxel, demonstrated antitumor activity in a randomized Phase 2 trial invoView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on October 11, 2010 at 11:06 pm By:

Drugs_Devices Drugs and Devices OW OW Health

Updated AMG 386 Data Demonstrate Promising Antitumor Activity in Patients With Recurrent Ovarian Cancer: THOU... http://bit.ly/b2PL9F #drug

2 years ago...

Ovarian Cancer

springer.com — “Ovarian carcinoma continues to be responsible for more deaths than all other gynecologic malignancies combined, due to a continued inability to achieve detection of early (rather than advanced) stage disease and the lack of ...View full resource at springer.com

  • View Related
  • Share

Most Recently Shared on March 16, 2012 at 6:27 pm By:

OvarianCancer_ Ovarian Cancer OW OW Health

Ovarian Cancer: Second Editionseries:Cancer Treatment and ResearchOvarian carcinoma continues to be responsible ... http://t.co/GanmC9SK

2 months ago...

Unique Genetic Marker May Improve Detection Of Recurrent Ovarian Cancer

medicalnewstoday.com — “Ovarian cancer is a major health concern for women and the identification of sensitive biomarkers for early detection and/or monitoring of disease recurrence is of high clinical relevance.View full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on December 9, 2011 at 9:07 am By:

mnt_ovariancanc MNT Ovarian Cancer Health News

Unique Genetic Marker May Improve Detection Of Recurrent Ovarian Cancer http://t.co/7OgdD8rC #ovariancancer

6 months ago...

Ovarian cancer advances when genes are silenced

eurekalert.org — “Researchers at the Duke Cancer Institute have found evidence of epigenetics at work on a genome-wide scale in cases of ovarian cancer. One major biological signaling pathway in particular was found to contain many genes influenced by DNA methylation -- a mechanism for turning off genes -- in tumor cells.View full resource at eurekalert.org

  • View Related
  • Share

Most Recently Shared on December 14, 2010 at 4:41 pm By:

twitterbo Bo Health Site

Ovarian cancer advances when genes are silenced ---> http://dld.bz/ANpD

1 year ago...

Ovarian cancer advances when genes are silenced

labspaces.net — “There are many mechanisms that alter the activity of genes -- direct changes to the DNA code like mutations and deletions, or changes that control when genes are switched on and off, called epigenetic means. Tumor-suppressor genes are often inactivated through epigenetics, which provides an opening for the cancerous growth of cells.View full resource at labspaces.net

  • View Related
  • Share

Most Recently Shared on December 14, 2010 at 4:48 pm By:

LabSpaces Brian Krueger Health News

Ovarian cancer advances when genes are silenced - http://is.gd/iJVou

1 year ago...

Key advances in ovarian cancer (ASCO 2010 ) Video

vodpod.com — “Prof Jonathan Ledermann outlines some of the key advances in ovarian cancer that have been presented at ASCO 2010. Prof Ledermann discusses research demonstrating the effectiveness of combining bevacizumab with chemotherapy as first line treatment of ovarian cancer. A second key presentation was research indicating that PARP inhibitors are effective at treating not just ovarian cancer caused by BRCA mutation but also high grade serous cancer. If this result is confirmed in further studies, it woView full resource at vodpod.com

  • View Related
  • Share

Most Recently Shared on July 22, 2010 at 9:59 pm By:

libbyshope Paul Cacciatore Patient Advocate

Prof Jonathan Ledermann outlines some of the key advances in ovarian cancer that have been presented at ASCO 2010. Pro… http://bit.ly/b7acun

2 years ago...

Ovarian cancer advances when genes are silenced

sciencedaily.com — “Researchers have found evidence of epigenetics at work on a genome-wide scale in cases of ovarian cancer. One major biological signaling pathway in particular was found to contain many genes influenced by DNA methylation -- a mechanism for turning off genes -- in tumor cells.View full resource at sciencedaily.com

  • View Related
  • Share

Most Recently Shared on December 14, 2010 at 3:38 am By:

OvarianCancer_ Ovarian Cancer OW OW Health

Ovarian cancer advances when genes are silenced: Researchers have found evidence of epigenetics at work on a gen... http://bit.ly/hM8eZ9

1 year ago...

7 Clues to Ovarian Cancer

webmd.com — “Seven symptoms often reported to doctors are associated with ovarian cancer, according to a new study from the U.K., dispelling the idea that the deadly cancer is a ''silent killer'' with few clues until the advanced stages.View full resource at webmd.com

  • View Related
  • Share

Most Recently Shared on August 25, 2009 at 11:47 pm By:

WebMD_News WebMD_News Health News

7 Clues to Ovarian Cancer: Seven symptoms often reported to doctors are associated with ovarian cancer, accordin.. http://bit.ly/17OJmo

3 years ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Related Health Centers

Featuring the top 3 experts for this topic

  • mnt_ovariancanc

    MNT Ovarian Cancer

    The latest ovarian cancer news published daily. Articles from research centers, universities and prestigious journals.

    View Profile

  • mnt_ovariancanc

    MNT Ovarian Cancer

    The latest ovarian cancer news published daily. Articles from research centers, universities and prestigious journals.

    View Profile

  • disabledworld

    Disabled World

    Disabled World is managed by Lynn and Ian Langtree, a couple dedicated to assisting seniors and people with disabilities.

    View Profile

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390